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ABSTRACT An emerging paradigm for degenerative diseases associated with protein misfolding, such as Alzheimer’s disease,
is the formation of a toxic species due to structural transitions accompanied by oligomerization. Increasingly, the focus in
Alzheimer’s disease is on soluble oligomeric forms of the amyloid-b peptide (Ab) as the potential toxic species. Using a variety of
methods, we have analyzed how sodium dodecyl sulphate (SDS) modulates the folding of Ab40 and 42 and found that submicellar
concentrations of SDS solubilize Ab and induce structural transitions. Under these conditions, Ab40 and 42 are interconverting
oligomeric ensembles with a predominantly b-sheet structure. The Ab42 soluble oligomers form b-sheet structures more readily
and have increased stability compared with Ab40 under identical conditions. The presence of added Cu21 signiﬁcantly promotes
and stabilizes the formation of the soluble oligomeric b-sheet structures but these structures are nonamyloidogenic. In contrast,
in the absence of added Cu21, these b-sheet oligomers possess the hallmarks of amyloidogenic structures. These SDS-induced
b-sheet forms of Ab, both in the presence and absence of Cu21, are toxic to neuronal cells.
INTRODUCTION
Amyloid-b peptide (Ab) is the major component of extra-
cellular neuritic plaques, which are one of the major patho-
logical hallmarks of Alzheimer’s disease (1,2). Ab is
produced by the proteolytic cleavage of the transmembrane
amyloid precursor protein to form predominantly Ab40 and
Ab42 (1). As the progression of AD is marked by neuro-
degeneration, an early hypothesis was that the accumulating
ﬁbrillar Ab deposits were neurotoxic (3,4). This neurotox-
icity was the result of a gain of toxic function as a conse-
quence of Ab undergoing a conformational transition to a
predominantly b-sheet structure accompanied by peptide
aggregation. Further evidence in support of the amyloid hy-
pothesis of AD was the identiﬁcation of a number of muta-
tions linked to early onset familial AD (5–9). However, there
is poor correlation between amyloid plaque burden and dis-
ease progression (10–12). More recent evidence has identi-
ﬁed smaller soluble b-sheet-rich oligomers of Ab as more
neurotoxic than amyloid ﬁbrils (13–20) and are more likely to
be the toxic agent (16,21–23) responsible for the observed
neurodegeneration. There is strong correlation between loss
of synaptic terminals and cognitive decline and the presence
of such oligomers (24).
Numerous studies have been undertaken to examine the
structural transitions of Ab and the associated gain of toxic
function, but interpretation of these studies has been compli-
cated by the tendency of Ab to form insoluble aggregates
which are difﬁcult to study. We have identiﬁed solution con-
ditions, using submicellar concentrations of sodium dodecyl
sulphate (SDS), that allow the generation of soluble b-sheet
conformers of Ab (40 and 42) that are more toxic to cultured
neuronal cells than freshly prepared solutions of Ab. Similar
conditions have recently been reported to generate so-called
Ab1-42 globulomers and a 16–20 kDa Ab oligomer (25).
The aqueous solubility of these b-sheet rich, soluble olig-
omers has allowed the use of a number of techniques including
circular dichroism (CD) nuclear magnetic resonance (NMR),
size-exclusion chromatography, isothermal calorimetry (ITC),
and ﬂuorescence spectroscopy to further characterize these
species. Data obtained are consistent with the existence of a
number of species undergoing conformational or chemical
exchange, rather than existing in a single conformational state.
The structural transitions observed for Ab40 are reversible,
while those for Ab42 (which has a greater tendency to form
b-sheet structures) are not fully reversible. Also, the presence
of Cu21 ions, implicated in the pathology of AD (26), is able
to signiﬁcantly stabilize the b-sheet oligomeric forms and
promote a nonamyloidogenic pathway.
MATERIALS AND METHODS
All chemicals were purchased from Sigma (St. Louis, MO) unless otherwise
stated.
Peptides
Synthetic Ab42 and Ab40 were purchased from W. M. Keck Laboratory
(Yale University, New Haven, CT) in lyophilized form.
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All Cu21 solutions were prepared in solution of one-part CuCl2 to six-
parts glycine. The addition of glycine counterions was essential to prevent
the formation of insoluble phosphate-metal complexes. The copper concen-
trations were determined by inductively coupled plasma-mass spectrometry
(ICP-MS).
Peptide preparation
Dry peptide was weighed and dissolved in 1,1,1,3,3,3-hexaﬂuoro-2-
isopropanol (HFIP) and incubated at 25C for 1 h to remove any preformed
aggregates. It was then aliquoted into small amounts and dried using a speed-
vac. The dry peptide was stored at80C. Aliquots to be used were dissolved
in 1/10 ﬁnal volume of 20 mM NaOH. This was diluted with phosphate
buffer, pH 7.4, followed by sonicationwith a probe at 0.5 s intervals for 1min
at 30% power, or in a sonicating water bath, chilled with ice, for 15 min. The
solution was then centrifuged in a benchtop centrifuge at 13,000 rpm for
20 min. The supernatant was stored on ice until used. Initial peptide con-
centrations were determined by amino-acid analysis and subsequently the
extinction coefﬁcients which were derived for absorbance at 214 nm were
55,771 liters/mol per centimeter for Ab40 and 75,887 liters/mol per centimeter
for Ab42.
CD spectroscopy
CD spectra were obtained using a model No. 810 spectropolarimeter
(JASCO, Tokyo, Japan) at 37C. Far-UVCD spectra were obtained from 190
to 260 nm with a 1-mm pathlength. The baseline acquired in the absence of
peptide was subtracted, and the resulting spectra were smoothed using a
Fourier transform.
SDS titrations
Ab was prepared as described and concentration adjusted to 20 mM. Two-
hundredmicroliters of Abwas placed in a 0.1-cm cuvette. A stock solution of
35 mM SDS was prepared and was sequentially titrated into the cuvette in
aliquots of 1 or 2 mL. CD spectra were measured as described.
Alpha-cyclodextrin is a cyclohexose able to sequester a wide range of
apolar molecules, including SDS, in its hydrophobic interior (27). The com-
plexation reaction is driven by several factors, including desolvation of the
guest molecule, van der Waals host-guest interactions, and extensive reor-
ganization of the a-cyclodextrins hydrogen-bond network upon complexa-
tion (28). Two molecules of a-cyclodextrin have been shown to strip one
molecule of bound SDS rapidly from proteins. To assess reversibility of the
conformational changes induced by SDS, a-cyclodextrin was prepared in
stock solution at 100mM and titrated into 20mMsolutions of Ab40 or Ab42
containing 3 or 8 mM SDS. The data were expressed as effective SDS con-
centrations, allowing for two molecules of a-cyclodextrin to sequester each
molecule of SDS. All titrations were carried out at 37C.
The data obtained from the titrations was analyzed using a three-state
model of folding (29), but because the process was not reversible, this ﬁtting
procedure was only used to obtain midpoints for each transition.
Thermal unfolding
Thermal unfolding of the peptide (concentration of 0.02 mg/ml) was moni-
tored by the changes in secondary structure as a function of temperature,
measured by monitoring the CD signal at 203 nm. A heating rate of 60C/h
was used and the temperature within the cuvette was maintained by a Peltier-
driven, computer-controlled water bath connected to a water jacket integral
to the cuvette holder and monitored by a sensor directly located in the holder.
The second derivative of the resulting data was then used to calculate the
inﬂection point of the transition and hence the midpoint for the thermal
transition. Full CD spectra were measured at 5C intervals to compare the
secondary conformations.
Synchrotron radiation circular-dichroism
(SRCD) spectroscopy
Synchrotron radiation circular-dichroism (SRCD) spectra were collected on
station 12.1 at the Daresbury Synchrotron Radiation Source. Data were
collected at 37C in a 0.01-cm fused silica cell, with a peptide concentration
of 90 mM and SDS concentrations, as required. Data were collected between
170 and 260 nm, and background readings of buffer in the absence of peptide
were subtracted. CD and SRCD spectra were deconvoluted using the
DICROWEB website (30,31) using the CONTIN program (32).
Neurotoxicity
Primary neuronal cultures
Cortical neuronal cultures were prepared as described previously under sterile
conditions (33). Brieﬂy, embryonic-day-14 BL6J 3 129sv mouse cortices
were removed, dissected free of meninges, and dissociated in 0.025% (w/v)
trypsin (Sigma) in Krebs buffer. The dissociated cells were triturated using a
ﬁlter-plugged ﬁne pipette tip, pelleted, resuspended in plating medium (mini-
mum Eagle’s medium, 10% fetal calf serum, 5% horse serum), and counted.
Cortical neuronal cells were plated into poly(D-lysine)-coated 48-well plates at
a density of 150,000 cells/well in platingmedium. All cultures weremaintained
in an incubator set at 37C with 5% CO2. After 2 h, the plating medium was
replaced with fresh neurobasal medium containing B27 supplements, genet-
icin, and 0.5 mM glutamine (all tissue culture reagents were purchased from
Invitrogen, Carlsbad, CA, unless otherwise stated). This method resulted in
cultures highly enriched for neurons (.95%purity) withminimal astrocyte and
microglial contamination, as determined by immunostaining of culture prep-
arations using speciﬁc-marker antibodies (data not shown).
Stuarosporine and copper chloride were purchased from Sigma. H2O2 and
glycine were purchased from BDH (VWR International, BDHMerck, Poole,
Dorset, UK). The quantity 10 3 PBS refers to Dulbecco’s 103 phosphate-
buffered saline consisting of 26.67 mM KCl, 14.71 mM KH2PO4, 1379.3
mM NaCl, and 80.60 mM Na2HPO4-7H2O.
For use in the neuronal cell viability assays the HFIP-treated dry peptides
were dissolved 20mMNaOH, sonicated for 15 min in an iced waterbath then
diluted in 103 PBS and deionized H2O at v/v/v ratio of 2:7:1. The solution
was then centrifuged in a benchtop centrifuge at 13,000 rpm for 20 min. The
supernatant was stored on ice until used.
Cell viability assays
The neuronal cells were allowed to mature for six days in culture before
commencing treatment using freshly prepared neurobasal medium plus B27
supplements minus antioxidants. For the treatment of neuronal cultures,
freshly prepared soluble Ab stock solutions were diluted to the ﬁnal concen-
tration in neurobasal medium. The mixtures were then added to neuronal cells
for up to four days. Cell survival was monitored by phase contrast microscopy,
and cell viability was quantitated using theMTS assay as described previously
(33). Brieﬂy, the medium was replaced with fresh neurobasal medium sup-
plemented with B27 lacking antioxidants, and 10% v/v MTS (Promega,
Madison, WI) was added to each well and incubated for 3–4 h at 37C in a 5%
CO2 incubator. Plates were gently shaken, and a 100-ml aliquot from each well
was transferred to separate wells of a 96-well plate. The color change of each
well was determined by measuring the absorbance at 490 nm using a Wallac
Victor Multireader (Wallac, PerkinElmer, Boston, MA), and background
readings of MTS incubated in cell-free medium were subtracted from each
value before calculations. The data were normalized and calculated as a per-
centage of untreated vehicle control values. Data are shown as mean 6 SE.
Statistical comparisons between groups were done using Student’s t-test.
Analysis of aggregate size
The product of the overnight incubations in 1 mM SDS was centrifuged to
pellet any insoluble aggregates and the supernatant was applied to a Superose
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75 column (Amersham Pharmacia Biotech, Uppsala, Sweden) for separation
by size exclusion. Commercial standards, prepared in identical solutions of
1 mM SDS, were used to calibrate the column.
SDS-PAGE
After overnight incubation at 37C, with shaking, the samples were resolved
by SDS-PAGE. The resolving matrix was a 16% Tris-Glycine SDS gel and
the membrane probed with the monoclonal antibody WO2 (34).
Isothermal calorimetry
Isothermal calorimetric titrations were performed using an Omega VP iso-
thermal titration calorimeter (MicroCal, Northampton,MA). All experiments
were performed at 37C. The data were analyzed using the evaluation soft-
ware, MicroCal Origin, Ver. 5.0, provided by the manufacturer. The binding
curve ﬁtted a single-site binding model in all cases and Kd values were de-
termined from experiments repeated at least twice. This methodmeasures the
amount of energy absorbed or released as a result of changes that occur
within the calorimeter bulb. For SDS critical micelle concentration (CMC)
determination, the calorimeter cell, which has an internal volume of 1.425
ml, contained phosphate buffer plus 2 mM NaOH at pH 7.4. It was titrated
with 29 injections of 10 ml of 56 mM SDS, to determine the CMC under
experimental conditions. For determination of the heat of binding of copper,
solutions of 20 mMAb in 1 mMSDS in the cell were titrated by injections of
a total of 290 mL 160 mM Cu21 . The heat of dilution of the Cu21 was
subtracted from the raw data of the binding experiment. For determination of
the heat of folding of Ab in SDS, the cell contained phosphate buffer, SDS,
and NaOH, as used for the peptide preparation with or without copper ions.
This was titrated with ﬁve injections of 50mL of peptide at 70mM. The value
of DH for each addition of peptide was plotted against the ﬁnal peptide
concentration and the values were ﬁtted to a linear regression. To ascertain
the DH of folding alone without any components of intermolecular interac-
tion, the linear regression was extrapolated to zero to give the true DH of
folding and the values shown later in Table 4 (a similar methodology is used
to ﬁnd the DG of unfolding in denaturant, where the unfolded baseline is
back-extrapolated to zero denaturant (35)).
NMR spectroscopy
NMR spectra were recorded at 37C on a model No. DRX-600 spectrometer
(Bruker Optics, Billerica, MA) equipped with triple resonance probes and
pulsed ﬁeld gradients operating at 600 MHz. The Ab40 or Ab42 sample was
prepared by dissolving 0.5 mg Ab40 in 55mL 2H2Omade up to 630mLwith
10 mM phosphate buffer pH 6.4. 15N-labeled Ab40 was purchased from
rPeptide (Athens, GA) and made to the same concentration in 10% 2H2O/10
mM phosphate buffer pH 6.4. Spectra were processed and analyzed using
XWINNMR (Bruker) or analyzed using XEASY (36).
Aggregation studies using Thioﬂavin T
(ThT) ﬂuorescence
Thioﬂavin T (ThT) is routinely used to indicate the presence of b-sheet
amyloidogenic structures. For detection of ﬁbril formation, 10 mM Ab40 or
Ab42 solutions were prepared as above either alone or in the presence of
SDS, with and without equimolar Cu21 or Zn21 with 20 mM ThT. Six-
hundred microliters of each sample was incubated at 37C in a stirred cu-
vette. The ThT signal was excited at 444 nm and emission was measured at
480 nm. Fluorescence was measured using a Varian Cary Eclipse ﬂuores-
cence spectrophotometer (Palo Alto, CA) ﬁtted with a Peltier-driven tem-
perature controller and a multicell holder. Readings were taken every 60 s for
the ﬁrst 15 min then every 15 min for the next 885 min. Slit widths were 5 nm
for both excitation and emission. In preliminary experiments, we showed that
ThT ﬂuorescence is not affected by the presence of SDS.
RESULTS
Critical micellar concentration (CMC)
determination of SDS
The CMC of SDS can vary depending on solution conditions
such as the concentration of counterions in the solution and
the temperature (37,38). SDS was titrated into the isothermal
calorimeter cell containing 10 mM phosphate buffer at pH
7.4 and 37C; these buffer and conditions were used for all
other experiments. Under these conditions, the CMC of SDS
was found to be 3.1 mM, and in the presence of 20 mMCu21,
the CMC was 3.4 mM (Supplementary Material, Fig. S1).
Far-UV CD
Submicellar SDS induces b-sheet conformation in
Ab40 and Ab42
Far-UV CD spectra were recorded as SDS was titrated into a
buffered aqueous solution of Ab peptides 1-16 (Ab16), 1-28
(Ab28), 1-40 (Ab40) or 1-42 (Ab42) (Fig. 1). All CD spectra
were analyzed using the CONTIN algorithm via the DI-
CHROWEB website (30,32); the results are summarized in
Table 1. Spectra obtained in the absence of SDS indicated
that all Ab peptides contained a high percentage of random
coil (i.e., conformationally averaged). Titration of SDS into
the peptide solutions revealed that although no conforma-
tional change was observed in the shortest peptide (Ab16)
(Fig. 1 a) there was a transition to an a-helical structure by
Ab28 (Fig. 1 b) as the SDS concentration reached the CMC.
The helical structure content is consistent with previously
reported structural studies using the Ab peptides in aqueous
solutions with high concentrations of SDS (39,40). However,
there was no isodichroic point observed for this transition to
indicate that the conversion from random coil to a-helical
structure did not proceed via a simple two-state mechanism.
When SDS was titrated into aqueous solutions containing
Ab40, a three-state transition from random coil through a
b-sheet-rich intermediate to an a-helical endpoint was ob-
served (Fig. 1 c). Under the conditions of this experiment, the
folding pathways of Ab40 involved the population of an
intermediate b-sheet-rich conformation at submicellar levels
of SDS, while the fully folded product was predominantly
a-helical in SDS concentrations above the CMC.
To examine the folding of Ab40 as a function of SDS con-
centration the relative far-UV CD signal measured at 203 nm
was plotted against SDS concentration (Fig. 2 a). 203 nmwas
selected because the magnitude of the CD signal is most sen-
sitive to changes in composition of secondary structure. These
data indicate that for Ab40 the midpoint of the transition from
the random coil-rich conformation to the b-sheet-rich con-
formation occurred at;0.6 mMSDS. Further addition of SDS
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led to a second conformational change resulting in the fully
folded conformation in micellar SDS; the midpoint of the
second transition was centered at ;2.3 mM SDS.
Cu21 stabilizes b-sheet conformation
A similar SDS titration was performed in an aqueous solution
of Ab42. Increasing SDS concentration lead to an increase in
the b-sheet content of the peptide (Fig. 1 d). However, a
predominantly a-helical conformation could only be ob-
served at SDS concentrations in excess of 8 mM SDS (see
Fig. 1 d, inset; Ab42 in 15 mM SDS). The SDS-induced
folding of Ab1-42 also displayed two transitions centered at
;0.4 and 3.1 mM SDS (Fig. 2 b). Cu21 ions have been
implicated in the pathology of AD and reported to have ex-
tensive effects on Ab structure, chemistry, and biology (26).
FIGURE 1 CD spectra of Ab peptides in increasing concentrations of SDS. (A) Ab (1-16), (B) Ab (1-28), (C) Ab40, and (D) Ab42 in phosphate buffer
(solid line); in 1.5 mM SDS (line with short dashes); 3 mM SDS (line with long dashes); and 8 mM SDS (line with alternating short and long dashes). (Inset)
CD spectrum of Ab42 in 15 mM SDS. Units shown are the per-residue molar absorption units of circular dichroism, measured in mdeg M1 cm1 plotted
against wavelength in nm. CD spectra in (E) Ab40 and (F) Ab42 showing the effects of decreasing concentrations of SDS when the a-cyclodextrin is titrated
into the solution to remove SDS. The effective SDS concentrations shown are: 0 mM (solid line); 1.5 mM SDS (line with short dashes); and 3 mM SDS (line
with long dashes).
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To examine the effect that Cu21 ions had on the folding
pathway of Ab, the titrations of SDS into Ab40 and Ab42
were repeated in the presence of one molar equivalent of
Cu21 (Fig. 2, a and b).
Titration of increasing amounts of SDS into a solution of
Ab40 containing equimolar concentrations of Cu21 resulted
in two structural transitions.
The ﬁrst transition was to a b-sheet-rich conformation
followed by a transition to increased a-helical conformation.
While the structural changes observed were unchanged by
the presence of Cu21, the concentration of SDS required to
induce these structural changes was signiﬁcantly decreased,
indicating that the pathway has been altered. The ﬁrst tran-
sition to a b-sheet-rich structure is centered at;0.4 mM SDS
while the second transition to an a-helical structure occurred
at 2.3 mM SDS. The difference in midpoints observed in the
presence (0.4 mM) and absence (0.6 mM) of Cu21 indicates
the transition from native random coil to the b-sheet-rich
intermediate state occurred at lower SDS concentration in the
presence of Cu21, with a qualitative estimated DDG of
;4.0 kcal/mol. The SDS-induced folding curves were ﬁt-
ted to a three-state model, using a nonlinear, least-squares
ﬁtting algorithm (29), the analysis of which suggests that the
energy required for the transition from unfolded structure to a
b-sheet conformation is signiﬁcantly lower in the presence of
Cu21. CD spectra (see Supplementary Material, Fig. S2) also
showed that the presence of Cu21 induced an increase in
local structure in the peptide consistent with the concept that
Cu21 stabilized the b-structure.When SDSwas titrated into a
solution of Ab42 containing equimolar Cu21 there was a
shift in the amount of SDS required to induce the structural
transitions. Once again, less SDS was required to initiate the
ﬁrst transition while more SDS was required for the second
transition. The DDG induced by the presence of Cu21 was
;1.4 kcal/mol, which is lower than that observed for Ab40,
which reﬂects the increased b-sheet content in the presence
TABLE 1 Deconvolution of CD spectra in varying
SDS concentrations
Ab
peptide
SDS
concentration
a-helical
content
(1Cu)
b-sheet
content
(1Cu)
b-turns
(1Cu)
Random
coil
(1Cu)
Ab(1-16) 0 10 33 25 32
Ab(1-16) 1 13 28 26 33
Ab(1-16) 3 14 27 25 34
Ab(1-16) 8 12 37 21 30
Ab(1-28) 0 14 28 24 34
Ab(1-28) 1 21 23 26 30
Ab(1-28) 3 28 18 23 31
Ab(1-28) 8 34 7 26 33
Ab(1-40) 0 16 (9) 25 (34) 24 (23) 35 (33)
Ab(1-40) 1 1 (3) 42 (41) 21 (21) 36 (34)
Ab(1-40) 3 31 (24) 15 (21) 22 (23) 32 (32)
Ab(1-40) 8 35 (28) 11 (19) 23 (21) 31 (32)
Ab(1-42) 0 15 (8) 25 (32) 22 (24) 38 (36)
Ab(1-42) 1 8 (8) 37 (39) 22 (21) 33 (32)
Ab(1-42) 3 14 (9) 39 (39) 16 (26) 32 (31)
Ab(1-42) 8 16 (7) 29 (39) 21 (22) 34 (33)
Ab(1-42) 15 28 18 21 33
a-cyclodextrin titration
Ab(1-40) 0 9 32 24 34
Ab(1-40) 1 14 29 24 32
Ab(1-40) 3 18 25 25 32
CD and SRCD spectra were deconvoluted using the DICROWEB website
(30,31) using the CONTIN program (32) Values in parentheses are for
spectra obtained in the presence of Cu21.
FIGURE 2 Folding and unfolding curves. (A)
Ab40 and (B) Ab42 folding when SDS was
titrated into solution in the absence (squares) or
presence (triangles) of equimolar Cu21. The
molar circular dichroism measured at 203 nm
was plotted against the SDS concentration. (C)
Ab40 and (D) Ab42 unfolding as a-cyclodex-
trin was titrated into the solution containing SDS
in the absence (squares) or presence (triangles)
of equimolar Cu21. The molar circular dichro-
ism measured at 203 nm was plotted against the
effective SDS concentration. The data in A, B,
and C were ﬁtted to a three-state model of fold-
ing (29); the data in D was ﬁtted to a two-state
model of folding (35). On each graph these are
represented by a solid line in the absence of
Cu21 and a dashed line in the presence of Cu21.
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of Cu21 by Ab42 in buffer. The addition of submicellar
concentrations of SDS did not induce any additional increase
the overall b-sheet content (Table 1).
A second transition was observed at higher SDS concen-
trations, but in the SDS concentration range used for the
titrations, a fully a-helical conformation was not observed.
In fact, in the presence of Cu21 this second transition resulted
in a signiﬁcant increase in the b-sheet content of Ab42.
Therefore, the presence of Cu21 had rendered the b-sheet
conformation extremely stable.
Alpha-cyclodextrin reverses SDS-induced
conformational changes
Two molecules of a-cyclodextrin have been shown to strip
one molecule of bound SDS rapidly from proteins (27).
Therefore, to assess reversibility of the conformational
changes induced by SDS, a-cyclodextrin was titrated into
aqueous SDS solutions of Ab40 and Ab42. When a-cyclo-
dextrin was titrated into the peptide solution in the absence of
SDS, no conformational changes to either peptide was ob-
served—indicating that there is no direct interaction between
a-cyclodextrin and Ab. Both Ab40 and Ab42 were prepared
in micellar SDS, and a-cyclodextrin was titrated into the
solutions. The Ab40 was in an a-helical conformation in
micellar SDS, and returned to a b-sheet-rich state in sub-
micellar SDS as the a-cyclodextrin was titrated into the so-
lution. The midpoint of this transition was 2.0 mM SDS
concentration (corresponding well with the midpoint of the
b-sheet to a-helix transition), demonstrating that this tran-
sition was fully reversible. Further addition of a-cyclodextrin
also showed that the transition from b-sheet-rich confor-
mation to random coil was clearly evident for the Ab40
peptide, with the transition centered at;1.2 mMSDS. This is
higher than the midpoint of the folding from random coil to
b-sheet-rich intermediate, which had a midpoint of 0.3 mM—
indicating that this change is not fully reversible, and may
proceed via a different unfolding pathway.
These titrations were repeated for Ab42 and there was a
structural transition to a more b-sheet-rich structure as the
apparent concentration of SDS decreased to below the CMC.
The midpoint of this transition was 2.8 mM SDS. Further
addition of a-cyclodextrin did not induce a transition to a
predominately random coil conformation, which is an indi-
cation of the inherent stability of the b-sheet conformation
for Ab42. The starting Ab42 solution was in 4 mM SDS for
these experiments, but it was prepared from peptide dissolved
in higher concentrations of SDS. It differed in conformation
from the endpoint peptide in the corresponding titration,
which increased the SDS concentration and showed a large
proportion of persistent b-sheet. The hysteresis in folding of
Ab42 in SDS occurred because the b-rich conformation is a
kinetic trap for the folding of Ab42. Representative CD
spectra from the a-cyclodextrin titration are shown in Fig. 1,
e and f.
The a-cyclodextrin titrations were repeated in the presence
of Cu21. The CD changes at 203 nm were plotted as a
function of SDS concentration (Fig. 2, c and d). These data
show that there are clearly different pathways for folding and
unfolding in the presence of Cu21. The midpoints of the
folding and unfolding transitions are shown in Table 2. These
results show that, in the presence of Cu21, there were sig-
niﬁcant differences in the midpoints of unfolding transitions
compared to the folding transitions (i.e., they are not re-
versible). This indicates that the structural differences in-
duced by the presence of Cu21 alter the folding and unfolding
pathways. With respect to Ab42; Cu21 stabilized the inter-
mediate b-sheet conformation to such an extent that the
peptide did not unfold completely, and a signiﬁcant pro-
portion of b-sheet persisted in the ﬁnal conformation free
of SDS.
Thermal denaturation from b-sheet or
a-helical conformations
The relative stabilities of the b-sheet-rich intermediates and
a-helical conformations were tested by performing thermal
denaturation experiments. When Ab40 in 1 mM SDS was
heated at 1C per min, the b-sheet conformation was lost and
the CD spectrum at 90C had a minimum at 200 nm, which is
diagnostic of being structurally undeﬁned. The midpoint of
transition (Tm) was 41C. The solution was then slowly
cooled and the b-sheet conformation was restored with a
similar Tm, showing that the conformational change from
b-sheet to a structurally undeﬁned form was reversible.
When the Ab40 was dissolved in micellar 3 mM SDS, the
CD spectra had double minima at 208 and 222 nm, indicating
an a-helical conformation. Thermal denaturation of the
a-helical structure to a random coil conformation occurred
with a single transition, with a Tm of 51.5C (Fig. 3 a), and
when the sequential CD spectra were overlaid, they revealed
an isodichroic point. The presence of an isodichroic point
is indicative of the presence of only two conformational
states populating the thermally induced unfolding pathway.
When cooled, the a-helical conformation was restored with
a similar Tm, indicating the reversibility of the conforma-
tional change.
TABLE 2 Midpoints of conformational transitions
Peptide
Midpoints of conformational transitions (mM SDS)
SDS titration a-CD titration
Buffer/
submicellar
SDS
Submicellar/
micellar
SDS
Micellar/
submicellar
SDS
Submicellar
SDS/
buffer
1-40 0.6 2.29 2.1 1.1
1-40 1 Cu 0.4 2.75 2.4 0.9
1-42 0.4 3.11 2.8
1-42 1 Cu 1 1.47 2.1
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b-sheet conformation in 1 mM SDS is resistant to
thermal denaturation
In 1 mM SDS, Ab42 displayed a b-sheet structure, but upon
heating to 90C, it lost some of its structure; however, the
conformation was still predominantly b-sheet at 90C. The
Tm for this transition was 82C. When cooled, the b-sheet
conformation was restored, but the Tm was 65C. Interest-
ingly, the CD spectrum of the refolded peptide in 1 mM SDS
after heating showed a higher CD signal maximum at 198
nm. It is possible that the loss of structure at 90C represented
a loss of the residual aggregation present in the starting so-
lution, and that the ﬁnal solution is a more homogeneous
solution of small b-rich oligomers. When Ab42 was dis-
solved in 3 mM SDS, it retained some b-sheet conformation
(Figs. 1 and 2). When this mixture was heated to 90C, there
was a sloping baseline which was probably due to disruption
of the SDS micelles, or small oligomers. There was also a
transition with a Tm of 80C. When this mixture was cooled
to 37C, there was a single transition with Tm of 63C. The
CD spectra measured before and after these melts overlaid
completely, indicating that the secondary conformation be-
fore and after melting was unchanged. The hysteresis ob-
served suggests that the unfolding involved overcoming a
kinetic barrier, such as dissociating oligomeric species,
whereas the folding was a cooperative event. By contrast,
when the Ab42 was dissolved in 15 mM SDS, the confor-
mation was a mixture of a-helix and b-sheet. Upon heating to
90C, the conformation had an increased amount of random
coil. The midpoint of this transition was 67.7C (Fig. 3 b).
When this was cooled, the CD spectrum indicated that the
peptide returned to its original conformation with a similar
Tm (Table 3).
Thermal stability is further increased by Cu21
The thermal melts for both peptides in 1 mM and 3 mM SDS
were repeated in the presence of Cu21, and an increase in the
Tm, consistent with the Cu
21 ions stabilizing the secondary
structure was observed. The CD signal measured at 195 nm
was plotted against temperature for Ab40 and Ab42 in the
absence and presence of Cu21, and the results are shown in
Fig. 3. The midpoints of the various transitions are shown in
Table 3.
Isothermal calorimetry
Small heat of conformational change (DH) when
b-sheet-rich intermediate is formed
ITCmeasures the energy change as a result of conformational
change or the binding of a ligand. When Ab40 was titrated
into 1 mM SDS at 37C, there was very little heat change
observed (DH ;0.3 kcal/mol), which is in agreement with
the thermal denaturation studies showing a Tm of 41C (i.e.,
only a small amount of heat was needed to cause the con-
formational change from random coil to b-sheet). The Ab42
peptide had a Tm of 45C, and it also displayed little heat
change with DH ;0.8 kcal/mol.
Submicellar SDS conformation signiﬁcantly stabilized in the
presence of Cu21
The titrations were repeated in the presence of Cu21 (Fig. 4
b). The value of DH for each addition of peptide was plotted
FIGURE 3 Thermal denaturation of Ab peptides in SDS; The thermal
denaturation was followed using circular dichroism in the far-UV region at
195 nm, which was plotted as ‘‘Fapp’’ (the apparent fraction folded) against
temperature. The curves were smoothed using a Fourier transform. (A) Ab40
and (B) Ab42, peptides in 1 mM SDS (solid line); 1 mM SDS1 Cu21 (line
with short dashes); 3 mM SDS (line with long dashes); and 3 mM SDS 1
Cu21 (line with alternating short and long dashes).
TABLE 3 Midpoints of thermal denaturations
Peptide
SDS
concentration
(mM)
Midpoints
of transition
37–90C
(Tm 37–90)
Midpoints
of transition
90–37C
(Tm 90–37)
Ab(1-40) 1 41 41
Ab(1-40) 1 Cu21 1 42.8 40
Ab(1-40) 3 51.5 51.5
Ab(1-40) 1 Cu21 3 48 and 69 50 and 69.9
Ab(1-42) 1 77 45.8
Ab(1-42) 1 Cu21 1 81.9 65.5
Ab(1-42) 3 53.8 and 80.2 62.9
Ab(1-42) 1 Cu21 3 58.1 and 86.3 69.2
Ab(1-42) 15 67.7
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against the ﬁnal peptide concentration and the values were
ﬁtted to a linear regression. The linear regression was ex-
trapolated to zero to give the true DH of folding and the
values shown in Table 4. (A similar methodology is used to
ﬁnd the DG of unfolding in denaturant, where the unfolded
baseline is back-extrapolated to zero denaturant (35).) When
the effects of SDS alone were subtracted, the heat of binding
to copper resulted in a difference in DH of 5.3 6 0.1 kcal/
mol for Ab40 and 7.3 6 0.2 kcal/mol for Ab42. The ITC
results are in agreement with the CD data, demonstrating that
the presence of Cu21 ions signiﬁcantly stabilized the inter-
mediate, b-sheet- rich conformation populated in submicellar
concentrations of SDS. The DH values calculated from ti-
tration of the peptides into submicellar SDS in the presence or
absence of copper ions differed, and it follows that this dif-
ference arises from differences in the conformational changes
in the peptides. This supports the notion that the folding
pathways for the peptides in the presence and absence of
copper are dissimilar.
Thermal parameters associated with binding Cu21 to the
b-sheet-rich conformation
Another set of titrations was carried out in which the Ab40
or Ab42 in 1 mM SDS solution were present in the bulb of
the ITC calorimeter and Cu21 was titrated in small incre-
ments, to determine the thermal parameters associated with
the binding of Cu21 . The thermal parameters provided DH
and DS, from which DG and K could be calculated using
Origin software. The data, shown in Table 5, are global ﬁg-
ures reﬂecting the combined effects of a number of different
processes including the coordination of Cu21 and the sub-
sequent structural transitions induced by the copper. As can
be seen, the DH and DG for binding of copper to both peptides
were similar when the peptides were already in the presence of
submicellar SDS, reﬂecting that the metal-binding event was
similar in each case.
NMR spectroscopy
Submicellar SDS induces a dynamic equilibrium of
interchanging species
Nuclear magnetic resonance (NMR) spectra were recorded
for Ab40 and 42 in an aqueous environment, at submicellar
SDS (1 mM) and above the SDS CMC (Fig. 5). The 1H NMR
spectrum of Ab40 in aqueous solution was indicative of a
peptide of 4.3 kDa molecular mass (Fig. 5 a). The titration of
SDS to a ﬁnal concentration of 1 mM induced line-broad-
ening of the spectrum of Ab40, indicating either the presence
of a dynamic equilibrium of interchanging species broaden-
ing the resonances and/or an aggregation process (Fig. 5 b).
Resonances due to the SDSwere also signiﬁcantly broadened
at the submicellar concentration, indicating that the SDS was
interacting with the Ab assembly. The addition of metal ions
had no effect on the broadened resonances observed at sub-
micellar SDS (data not shown). The addition of further SDS
beyond the CMC caused a further structural transition and of
the 1H NMR spectrum, reﬂecting the formation of the ex-
pected a-helical Ab40 as previously described (40,41). This
is further demonstrated by the 1H-15N HSQC spectra of
Ab40. Before addition of SDS, there is a relatively small
dispersion of amide resonances, and after addition of SDS to
a ﬁnal concentration of 8 mM, there is increased spectral
dispersion (see Supplementary Material, Fig. S3). At the
intermediate concentration of SDS, the broadening of the
HSQC peaks was so severe that no peaks were observed.
FIGURE 4 ITC titrations. (A) Ab40 (dash-square-dash line) or Ab42
(dash-circle-dash line) were titrated into the calorimeter bulb (MicroCal) at
37C containing 1 mM SDS; or Ab40 (dash-square-dash line) or Ab42
(dash-circle-dash line) were titrated into the calorimeter bulb at 37C
containing 1 mM SDS and Cu21. The resulting DH values were plotted as a
function of the ﬁnal concentration of peptide. This was ﬁtted to a linear
regression and extrapolated to zero to determine the DH for peptide titrated
into 1 mM SDS alone or in the presence of an excess of Cu21. (B) Titration
of Ab40 (shaded representation) and Ab42 (solid representation) into
1 mM SDS, 1 mM SDS plus excess Cu21. SDS was titrated into 10 mM
phosphate buffer with 2 mMNaOH at pH 7.4 at 37C. Midpoint of transition
is at 3.0 mM SDS.
TABLE 4 DH kcal/mol of structural changes in Ab peptides in
1 mM SDS and for binding of Ab peptides to Cu21 in 1 mM SDS
1 mM SDS 1 mM SDS 1 Cu
Ab(1-40) 0.3 6 0.1 5.6 6 0.1
Ab(1-42) 0.8 6 0.2 8.1 6 0.1
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Ab40 in the absence and presence of SDS is structured as
shown by the 1H,15N HSQC (see Supplementary Material,
Fig. S3). Similar results were achieved with Ab42 (data not
shown).
Fluorescence studies
ThT-active structures induced in submicellar
SDS environment
Thioﬂavin-T (ThT) ﬂuorescence was used to monitor the
presence of amyloidogenic material in solutions of Ab40 and
Ab42 in the presence and absence of SDS and Cu21 ions
(Fig. 6, a and b). Ab40 did not form ThT-positive species in
the absence of SDS during an overnight incubation, with or
without the addition of Cu21. Similarly, in the presence of 3
mM SDS, Ab40 did not form ThT-active species. In 1 mM
(submicellar) SDS, ThT-active species were formed, indi-
cating the presence of amyloidogenic-like material; however,
in the presence of Cu21 ions, the formation of ThT-active
species was inhibited (Fig. 6 a). After overnight incubation in
the presence of Cu21, EDTA was added to sequester the
Cu21 ions, to determine whether the lack of ThT ﬂuorescence
was due to quenching of the ThT signal. There was only a
small increase in signal in the presence of EDTA, indicating
that, while there was some quenching of the ﬂuorescence by
Cu21, the level of ﬂuorescence was low, because the stable
b-sheet-rich structures formed in the presence of Cu21 were
not ThT-active.
Ab42 in aqueous buffer rapidly formed a small amount of
ThT-active species, possibly seeded by preexisting oligo-
mers, but in 8 mM SDS it was unable to form a ThT-active
species. In 1 mM SDS, Ab42 rapidly formed a large amount
of ThT-active species. To ﬁnd the solubility of the ThT-
positive species, the mixtures were centrifuged at 13,000 g
for 20 min after the aggregation assay to pellet any insoluble
(ﬁbrillar) material, and the ﬂuorescence emission spectra of
the supernatant fractions were determined. As shown in Fig.
6 d, 90% of the ThT ﬂuorescence of the peptide in 1 mMSDS
was present in the soluble fraction, while only 50% of the
TABLE 5 Thermal parameters derived by titrating Cu21 into solutions of Ab in 1 mM SDS
Peptide
DH in Ab titration into
1 mM SDS (kcal/mol)
DH in Ab titration into
1 mM SDS and Cu (kcal/mol) Peptide
DDH
(kcal/mol)
DS
(kcal/mol/C)
DG
(kcal/mol) K
Ab (40) 0.1 5.6 6 0.1 Ab(1-40) 6.9 6 0.1 2.73 8.8 486,000 6 3220
Ab (42) 0.5 8.1 6 0.1 Ab(1-42) 7.4 6 0.2 6.07 8.2 638,000 6 54,400
These ﬁgures were obtained using the software ORIGIN (MicroCal) to analyze the isothermal titration calorimetry (ITC) data obtained using a Microcal VP-
ITC instrument, and reﬂect the combined effects of a number of different processes including the coordination of Cu21 and the subsequent structural
transitions induced by the copper.
FIGURE 5 1H NMR spectra of Ab40. (A) In aqueous
solution, (B) in the presence of 1 mM SDS, and (C)
micellar SDS.
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ThT ﬂuorescence of peptide in buffer resided in the soluble
fraction. As observed with Ab40, the presence of Cu21 ions
inhibited the formation of ThT-active species. Analysis of
the SDS titrations by far-UV CD showed that the maximum
b-sheet content occurred at ;1 mM SDS. These data indi-
cate that this species corresponds to a ThT-positive, soluble
b-sheet-rich species, which is stable even after overnight in-
cubation at 37C in 1 mM SDS.
Size-exclusion chromatography
Analysis of aggregate size indicates presence of oligomers
The products of the overnight incubations in 1 mMSDSwere
centrifuged to pellet any insoluble aggregates and the su-
pernatant were applied to a Superose 75 column (Amersham
Pharmacia Biotech) for separation by size exclusion. Com-
mercial standards, prepared in identical solutions of 1 mM
SDS, were used to calibrate the column.
The Ab40 samples (Fig. 7 a) had a small peak corre-
sponding to an apparent weight of ;4 kDa (monomer);
however, the majority of the protein was present as a mixture
of small oligomeric species with apparent weights between 9
and 15 kDa and a small peak with a higher weight of ;70
kDa. In the presence of Cu21, there were peaks with apparent
weights between 9 and 15 kDa; however, the elution proﬁle is
different from that produced in the absence of Cu21, con-
sistent with the oligomers having different conformations, as
indicated by the ThT ﬂuorescence studies (see above).
Ab42 in 1 mM SDS (Fig. 7 c) showed a very large per-
centage of the product at a much higher molecular-weight
range, predominantly in the region of 60–70 kDa, with
smaller peaks in the 12 and 4 kDa regions. Interestingly, the
38–48 KDa ‘‘globulomers’’ produced by Baghorn et al. (25)
also eluted from size-exclusion chromatography in the same
molecular-weight range. The elution proﬁle upon addition of
Cu21 showed a decrease in the peak at 70 kDa.
After overnight incubation at 37C, with shaking, the
samples were resolved by SDS-PAGE, transferred to nitro-
cellulose membranes, and analyzed by Western blotting with
the WO2 antibody (Fig. 8). The Ab40-alone sample (Fig. 8,
lane 1) migrated as a smear, with distinct bands corre-
sponding in molecular mass to monomer, dimer, and trimer
species, plus higher-weight oligomers at 50 kDa and greater.
The Ab42-alone reaction displayed a different pattern than
Ab40, with distinct monomer, trimer, and tetramer bands,
plus a large oligomeric species above 100 kDa (Fig. 8 b,
lane 1). There was very little dimer species detected in the
blot. Incubating Ab40 with 1 mM SDS alters the oligomeric
pattern, with the predominant species corresponding to
monomeric Ab and some dimer also present. The Ab42-
plus-1 mM SDS reaction also generated monomer and small
oligomers, but there was an increase in the large oligomeric
species above 100 kDa. In the presence of Cu21, bands
corresponding to trimer were observed with Ab40 (Fig. 8,
lane 3). Incubating Ab42 in the presence of Cu21 (Fig. 8,
lane 3) showed a smaller band in the high molecular-weight
range than that without Cu21 in 1 mMSDS, corresponding to
the decrease in the 70 kDa peak in the size-exclusion chro-
matography. In micellar SDS (3 mM, 8 mM), only monomer
and dimer bands were present on the Ab40 gel (Fig. 8, lanes 5
and 6). The Ab42-plus-micellar SDS reduced the amount of
higher order oligomers and this was most pronounced at the
highest SDS concentration used (8 mM).
FIGURE 6 Thioﬂavin-T (ThT) ﬂuorescence
in the presence or absence of Ab peptides and
metal ions; growth of ThT-active oligomers
was monitored using ThT ﬂuorescence. The
ﬂuorescence was plotted against time. (A)
Ab40 and (B) Ab42 in phosphate buffer (n);
in 1 mM SDS (:); 1 mM SDS1 Cu21 (=); PB
1 Cu21 (d); 3 mM SDS (;); and 8 mM SDS
(*). Spectra of ThT ﬂuorescence in (C) Ab40
and (D) Ab42 measured after overnight incu-
bations at 37C, total sample in buffer (solid
line); supernatant of sample in buffer after
centrifugation (line with alternating short and
long dashes); total sample in 1 mM SDS (line
with long dashes); and supernatant of sample in
1 mM SDS after centrifugation (line with short
dashes).
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Neuronal cell culture
Ab40 and Ab42 b-sheet conformations are toxic
The toxic effect of Ab peptides has been associated with
structural transitions to small oligomers, some of which have
increased b-sheet conformation (42). To ascertain whether
the submicellar SDS-induced changes in Ab conformation
resulted in altered toxic properties, the viability of cortical
neuronal cell culture in the presence of Ab in submicellar
SDS solutions was determined. The effect of SDS on the cells
was tested ﬁrst, and when the ﬁnal SDS concentration was
#0.2 mM, there was no effect on cell viability (see Supple-
mentary Material, Fig. S4).
In the absence of SDS, 10 mM Ab40 was nontoxic to the
neuronal cell cultures. However, in the presence of SDS,
the Ab40 had a toxic effect on cell viability that was dose-
dependent for SDS—indicating that the b-sheet oligomers
of Ab40, induced by the presence of submicellar SDS, were
toxic (Fig. 9 b). The toxic effect of the Ab42 in the presence
of SDS was also shown to be dose-dependent for SDS (Fig. 9
b). To determine whether the effects of SDS were speciﬁc for
Ab peptide, non-Ab peptide neurotoxic agents, H2O2, and
staurosporine (a broad spectrin kinase inhibitor), were ex-
amined in the presence of SDS. The addition of SDS had no
effect on the amount of toxicity for either H2O2 or staur-
osporine at the different concentrations tested. These exper-
iments conﬁrm that the SDS effect was speciﬁc for Ab
peptide (Fig. 9 a). When the Ab peptides were preincubated
in SDS and equimolar copper, they were both shown to be
toxic to neuronal cells (Fig. 9 c).
DISCUSSION
In recent work, Ab40 was studied in the presence of micellar
SDS (43). The authors concluded that the increased rate of
aggregation observed in the presence of SDS micelles was a
result of the effective increase in concentration of Ab in the
two-dimensional space on the surface of the micelles. In
contrast, our work demonstrates the formation of stable,
soluble b-sheet-rich oligomers of both Ab40 and Ab42 at
much lower peptide concentrations (10 mM) in solutions
containing submicellar SDS. The increased aggregation we
observe is driven by structural transitions rather than effec-
tive increases in the local concentration of the peptide which
has not been previously demonstrated to our knowledge.
FIGURE 7 Size-exclusion chromatography. (A) Ab40 in 1 mM SDS after
overnight incubation at 37C with stirring; (B) Ab40 in 1 mM SDS and
equimolar Cu21, after overnight incubation at 37C with stirring; (C) Ab42
in 1 mM SDS after overnight incubation at 37C with stirring; and (D) Ab42
in 1 mM SDS and equimolar Cu21, after overnight incubation at 37C with
stirring.
FIGURE 8 SDS-PAGE. (A) Ab40 and (B) Ab42, both gels loaded with Ab
incubated overnight at 37C with shaking. LaneM contains molecular-weight
markers. Lane 1, Ab; lane 2, Ab in 1 mM SDS; lane 3, Ab in 1 mM SDS 1
Cu21; lane 4, Ab in 1 mM SDS1 Zn21; lane 5, Ab in 3 mMSDS; and lane 6,
Ab in 8 mM SDS. The resolving matrix was a 16% Tris-Glycine SDS gel and
the membrane probed with the monoclonal antibody WO2 (59).
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These oligomers were formed in the absence of metal ions,
using chelex-treated buffers, conditions in which Ab40 and
Ab42 are normally stable in solution (44). This work has also
correlated the formation of stable soluble oligomers of both
Ab40 and Ab42 with an increase in the toxicity of the pep-
tides in neuronal cell culture.
While SDS is not a physiological substance, Barghorn
et al. (25) have raised antibodies against oligomers generated
by treating Ab42 with submicellar SDS. These antibodies
demonstrated cross-reactivity with brain tissue from AD
patients and transgenic mice. These SDS-Ab oligomers were
able to bind to the dendritic processes of neurons but not glia
in hippocampal cell cultures and could block long-term po-
tentiation in rat hippocampal slices. In the present work we
have shown that the soluble oligomers of Ab40 and Ab42,
prepared in submicellar SDS, showed a dose-dependent in-
crease in toxicity. The conformation-activity relationship
induced by the SDS is not known and therefore our bio-
physical studies have provided important molecular insights
and indicate that, in the presence of submicellar SDS, both
Ab40 and 42 generate an interconverting ensemble of solu-
ble b-sheet oligomers (Figs. 1 and 2).
We began by investigating the effect of the SDS concen-
tration on the conformation of different length Ab peptides.
The shorter Ab peptides, Ab16 and Ab28, which correspond
to the extracellular N-terminal region of the peptide, are not
toxic to cultured neuronal cells (45,46). Ab16 is natively
unstructured in aqueous solution and the titration of SDS
caused no change in secondary conformation (Fig. 1), which
indicates that it is the hydrophobic C-terminal domain of the
longer peptides that drives the secondary structure transitions
in Ab. When SDS was titrated into a solution of Ab28, there
was an increase in a-helical content at SDS concentrations
above the CMC, consistent with previous results (39,40).
While no b-sheet structure was detected at submicellar SDS
concentrations, neither was an isodichroic point observed—
indicating that the structural transition did not occur as a
single transition. One interpretation of this result is that at
submicellar concentrations of SDS, Ab28 transiently in-
habits b-sheet conformations. Ab40 and Ab42 are pre-
dominantly in an a-helical conformation in micellar SDS as
previously reported (39,40); however, at submicellar con-
centrations of SDS, both peptides were predominantly in a
b-sheet conformation (Fig. 1).
The reversibility of the observed structural transitions was
established by titrating a-cyclodextrin, which can bind SDS
and strip it from proteins (27), into the SDS/Ab solutions.
Titration of a-cyclodextrin into micellar SDS solutions of
Ab40 showed the structural transition from a-helical to in-
termediate b-sheet conformation to be reversible, whereas
the transition from b-sheet to random coil was not. Therefore,
the folding and unfolding of Ab most likely occurs via dif-
ferent pathways or becomes trapped in a misfolded state
(Fig. 2). The folding of Ab in SDS is not a reversible process
at a given SDS concentration in either the folding or un-
folding transition regions (47). The hysteresis observed in the
chemical unfolding was mirrored in the thermal unfolding
(Fig. 3) and indicates that there are tertiary or quaternary
contacts involved. Both inter- and intraoligomeric contacts,
which must be broken before unfolding can occur, delay
FIGURE 9 Toxicity assay. (A) The percent-
age cell survival of neuronal cells in the pres-
ence of Ab40, Ab42, H2O2, and staurosporine
in neurobasal medium (light-shaded represen-
tation) and neurobasal medium containing 0.2
mM SDS (light-shaded representation). (B)
The percentage cell survival of neuronal cells
in the presence of Ab40 (light-shaded repre-
sentation) and Ab42 (medium-shaded repre-
sentation) in the presence of increasing
concentration of SDS. (C) The percentage cell
survival of neuronal cells in neurobasal me-
dium, showing the toxicity of Ab40 and Ab42
in culture medium to which PBS (solid repre-
sentation), PBS 1 Cu21 (medium-shaded rep-
resentation), 0.2 mM SDS (light-shaded
representation), or 0.2 mM SDS 1 Cu21
(open representation) has been added. Results
are normalized and the data expressed as a
percentage of the vehicle controls. Experiments
are done in triplicate and results are expressed
as mean 6 SE. N ¼ 3–7 for different treatment
groups. Statistical comparisons between PBS
alone and the different treatment groups were
performed using Student’s t-test. Asterisk indi-
cates p , 0.05.
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initial unfolding but are not reformed on folding. The dif-
ferences between folding and unfolding were more marked in
Ab42.
While the exact mechanism of ThT binding to ﬁbrils to
cause increased ﬂuorescence is unknown, recent work by
Khurana et al. (48) has shown that ThT forms micelles at
concentrations commonly used to study ﬁbril growth by
ﬂuorescence assay (10–20 mM), which have a CMC of ;4
mM. Their data suggest that the positive charge on the ThT,
combined with a nonpolar region, aid in the formation of ThT
micelles and that the positive charges are then involved in
binding in the grooves between the protoﬁbrils of amyloid
ﬁbrils, enhancing the ﬂuorescence of the ThT (48). Not all
b-sheet structures are ThT-active.
Since the percentage of b-sheet content increased in the
presence of SDS and Ab is known to form amyloidogenic
structures, ThT ﬂuorescence was used in conjunction with
overnight incubations at 37C to monitor any increase in
ThT-active b-sheet content in the peptide solution. In the
timeframe of this experiment, Ab40 and Ab42 did not form
ThT-active aggregates in the absence of SDS or in the pres-
ence of micellar SDS. However, in the presence of sub-
micellar SDS, ThT-positive structures were rapidly induced.
ThT binds in the hydrophobic-tail region of the peptide,
which becomes b-sheet in low SDS concentrations.
1H NMR spectra of the Ab peptides in submicellar SDS
were very broad, indicating that the amyloidogenic b-sheet
structures were either very large and/or were in a dynamic
equilibrium between different conformers such that the rate
of exchange between the conformers was in the intermediate
timeframe (;mM) of the NMR experiment. The presence of
several different-sized species was conﬁrmed by size-exclusion
chromatography and SDS-PAGE analysis.
Without prior aging of the peptide in solution we have
found that Ab40 is reproducibly nontoxic to neuronal cell
cultures. However, when incubated in submicellar SDS, to
generate an interconverting ensemble of b-sheet oligomeric
forms, the Ab40 was toxic. The induction of toxicity in the
normally nontoxic Ab40 suggests that the toxicity is con-
formation-dependent rather than sequence-dependent, and is
consistent with the notion that soluble b-sheet-rich oligomers
of Ab represent the toxic species (10,49).
Although Ab42 is the predominant alloform present in
senile plaques, the level of Ab42 has also been observed to
increase in the normal aging brain, present in diffuse cortical
plaques. However, a disease-speciﬁc increase in the relative
level of Ab40 in the brains of AD patients has been reported,
suggesting that a substantial increase in Ab40 may be det-
rimental to normal neuronal function, precipitating oligo-
merization and toxicity (50). Thus, the toxicity data presented
for the Ab40 peptide is particularly signiﬁcant.
The biophysical data shows that Ab42 more readily forms
b-sheet structures and that once formed, these structures are
more stable (Figs. 1 and 3, Table 3), consistent with the in-
creased toxicity demonstrated by this peptide.
Ab interactions with metal ions are believed to be im-
portant in the development of AD (26,51). Transition metals
such as copper, iron, and zinc are present in Ab plaques and
have been implicated as a signiﬁcant pathological risk factor
in AD (52). In vivo, amyloid plaques taken from AD-affected
brains are enriched in copper (;400 mM), zinc (;1 mM),
and iron (;1 mM) (53–55). The solubilization of Ab from
post-mortem brain tissue of AD patients is increased in the
presence of metal chelators such as n,n,n9,n9-tetrakis(2-pyr-
idyl-methyl)-ethylene-diamine and bathocuporine (56). In-
deed, the use of the prototypic metal protein attenuating
compounds such as clioquinol, a moderate metal chelator
capable of inhibiting Ab/Cu interactions, has shown promise
as a therapeutic agent in both animal (57) and human clinical
studies (58). Ab in the presence of copper has been dem-
onstrated to be toxic to primary cortical neurones (59,60) and
a potent inhibitor of the mitochondrial electron transport-
chain complex cytochrome c oxidase (also known as com-
plex IV) (61).
An emerging paradigm linking a number of degenerative
diseases states that normal transient intermediate conforma-
tions of the causative protein agent accumulate and aggregate
to form soluble b-sheet-rich oligomers and these soluble olig-
omers are the toxic agents (23). With regard to AD, soluble
oligomers of Ab have been isolated from brain tissue (22) and
correlate with the severity of neurodegeneration in AD (10).
CONCLUSION
Previously the ability to study the structural transitions as-
sociated with the formation of b-sheet oligomeric structures
has been hampered by the lack in solubility of the oligomeric
species. In this study, we have been able to generate stable
soluble oligomeric forms of Ab using submicellar concen-
trations of SDS, and this oligomerization has been driven by
structural transitions in both Ab40 and Ab42 at low, physi-
ologically relevant concentrations (56).
A range of biophysical data presented here indicates that
the presence of Cu21 signiﬁcantly shifts the Ab monomer-
oligomer equilibrium, such that the formation and stability of
soluble oligomeric b-sheet species is promoted by the pres-
ence of Cu21 and these soluble oligomeric forms of Ab are
toxic to neuronal cells.
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